AbCellera Biologics Inc.

NASDAQ:ABCL

2.74 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -36.93-40.61-47.15-28.61-30.528-40.11-29.89326.624-6.785168.57359.948-21.382-2.323117.221117-2.6926.703-2.093-1.6410.036-0.303-0.303
Depreciation & Amortization 38.0376.7669.1097.4097.2567.1215.366.7286.0414.9734.8634.2064.2153.9662.6080.9371.080.6460.4970.2930.5280.528
Deferred Income Tax 001.96000-2.0270001.249-4.0230.1330.6235.9750000000
Stock Based Compensation 17.78217.40916.44815.86216.39915.47413.32311.75412.11312.2919.0387.7088.4735.4274.6221.9320.6061.2370.1120.4620.1580.158
Change In Working Capital -7.787-26.981.4097.15827.571-22.91328.993-175.494261.352-85.026-94.4926.252147.413-17.501-129.318-4.66217.805-0.5260.992-0.6481.281.28
Accounts Receivables -15.614-18.576-10.438-11.226-32.1847.915-19.043.2881.788-8.751-3.057-5.991.734-30.073-1.8995.65217.391-26.611-0.833-1.6030.1380.138
Change In Inventory 00-7.77114.96636.72800000-93.512-0.263121.0913.604-112.8120-1.4900000
Change In Accounts Payables 4.749-4.878-13.2520.9752.951-5.7782.2170.731-2.6330.7511.7133.3271.554-5.194-1.511.381.666-0.1560000
Other Working Capital 3.078-3.52632.872.44320.076-25.0545.816-179.513262.197-77.0260.3649.17823.0354.162-13.096-10.3150.23826.2411.8250.9551.1421.142
Other Non Cash Items 64.16156.102-1.387-1.925-0.795-3.6345.1563.6020.294-0.5922.6821.307-0.228-0.1910.390.685-0.217-0.0280.499-0.948-0.144-0.144
Operating Cash Flow -29.459-41.708-19.611-0.10619.903-44.06330.912-126.786273.015100.219-16.712-5.932157.683109.5451.276-3.79925.977-0.7640.459-0.8051.521.52
Investing Activities:
Investments In Property Plant And Equipment -19.797-24.14-14.431-20.891-27.201-14.984-12.33-14.513-31.322-14.495-9.43-8.574-36.804-3.644-1.502-3.885-3.703-5.583-0.583-0.061-1.676-1.676
Acquisitions Net -4.913-5.907-3.476-3.541-2.204-4.469-5.909-4.076-7.359-8.335-3.218-18.052-8.315-12.195-87.6430000000
Purchases Of Investments -174.073-259.663-284.728-215.783-170.161-395.487-93.551-541.837-82.532-63.431-29.396-257.814-13.746-12.19500000000
Sales Maturities Of Investments 232.945306.545268.024220.099160.176262.63892.393272.4388.51457.29418.0819.5270000000000
Other Investing Activites 12.4427.16810.2887.3352.6932.3346.0025.5022.59622.8145.287-0.514-12.195-106.6801.573-5-0.045-0.197-0.771-0.771
Investing Cash Flow 51.51829.91-24.323-12.786-34.39-149.609-17.063-281.994-27.197-26.371-1.149-269.626-45.633-15.839-108.182-3.885-2.13-5.583-0.628-0.258-2.447-2.447
Financing Activities:
Debt Repayment -2.341-2.124-3.95-7.002-0.148-0.49-0.349-0.231-0.234-1.941-1.823-0.019-0.107-1.716-2.971-15-0.062-2.033-0.111-0.03100
Common Stock Issued 0.4510.89200-0.490.49-2.3630.1970.2251.9411.8210.8561.7390.17300000000
Common Stock Repurchased 00000000000-2.7550000000000
Dividends Paid 0000000000000000000000
Other Financing Activities -0.18-0.185-0.185-0.3720.271-0.9480.412-0.250.939-5.0723.6570.898-4.9680.173612.9110.6290.40889.7710.360.017-0.051-0.051
Financing Cash Flow 2.6122.8313.7656.630.419-0.4580.349-0.0191.173-3.1311.8340.898-5.075-1.543609.94-14.3710.34687.7380.2480.048-0.051-0.051
Other Information:
Effect Of Forex Changes On Cash -0.043-0.7811.068-1.0630.797-0.2130.364-8.552-1.207-0.204-0.525-0.217-0.199-0.4840-0000000
Net Change In Cash 24.74-11.348-39.102-7.325-13.27-194.34314.562-417.351245.78470.513-16.552-274.877106.77691.679503.034-22.05524.19381.3910.08-1.015-0.978-0.978
Cash At End Of Period 173.312148.572160.61199.712207.037220.307414.65400.088817.439571.655501.142517.694792.571685.795594.11691.082113.13788.9447.5537.4738.489-0.978